-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Seres Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2020 to Q2 2024.
- Seres Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 152M shares, a 16.7% increase year-over-year.
- Seres Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 128M shares, a 18.4% increase from 2022.
- Seres Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 108M shares, a 17.9% increase from 2021.
- Seres Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 91.7M shares, a 14.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)